Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASAQ efficacy and safety for uncomplicated falciparum and vivax malaria in Eritrea
ACTRN12619000859189Phase 4Not yet recruiting
- Sponsor
- Ministry of Health
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate and amodiaquine in Malaria and malaria, sponsored by Ministry of Health. Primary endpoints: Percent of treatment failures and Adequate clinical and parasitological response. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
artesunateamodiaquine
03
Conditions
Malariamalaria
Beyond the preview
Go deeper on ACTRN12619000859189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000859189.